Alto Neuroscience, Inc.: cashflow_financing
| Value | {"amount": 9740000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-06-30 |
| Status | current |
| Entity | Alto Neuroscience, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:03:50.334483+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d1c225be-b3f5-4459-94a6-64a76266a026
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001999480-25-000076Retrieved: 2026-08-19T19:03:50.334483+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001999480/cashflow-financing/2025-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d1c225be-b3f5-4459-94a6-64a76266a026
History
- no predecessors — first report